XML 22 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues:    
Rental income $ 16,470,918 $ 18,523,813
Fees and other income 343,790 401,462
Total revenue 16,814,708 18,925,275
Costs and expenses:    
Rental operating costs 6,158,052 6,256,077
General and administrative 5,704,830 7,526,675
Depreciation and amortization 4,862,267 5,515,518
Asset Impairment Charges 6,443,437 1,969,311
Total costs and expenses 23,168,586 21,267,581
Other income (expense):    
Interest and other income, net 20,881 (151,356)
Gain on sales of real estate, net 5,444,792 3,426,572
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9) (188,287) (17,925,723)
Income tax (expense) benefit (463,170) (60,855)
Total loss, net (1,236,221) (20,761,558)
Net loss: (7,590,099) (23,103,864)
Less: Income attributable to noncontrolling interests (685,586) (2,524,665)
Net loss attributable to Presidio Property Trust, Inc. stockholders (8,275,685) (25,628,529)
Less: Preferred Stock Series D dividends (2,295,607) (2,236,696)
Net loss attributable to Presidio Property Trust, Inc. common stockholders $ (10,571,292) $ (27,865,225)
Net loss per share attributable to Presidio Property Trust, Inc. common stockholders:    
Basic & Diluted (in dollars per share) $ (8.65) $ (22.5)
Weighted average number of common shares outstanding - basic & dilutive (in shares) 1,221,413 1,238,659
Mortgage Notes [Member]    
Other income (expense):    
Interest expense - mortgage notes $ (6,050,437) $ (6,050,196)